Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluation of Ultralow Dose PET Imaging for Detecting SSTR2 Radiotracer Uptake
NCT07284589Phase 2Recruiting
- Sponsor
- Akiva Mintz
- Start
- Dec 2025
- Primary completion
- Apr 2030
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gallium ga 68 dotatate in Neuroendocrine Neoplasm (NEN), sponsored by Akiva Mintz. Started Dec 2025; status: recruiting.
02
Drugs
gallium ga 68 dotatate
03
Conditions
Neuroendocrine Neoplasm (NEN)
Beyond the preview
Go deeper on NCT07284589.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07284589.